Catch up on the most important updates from this week.
Pfizer seeks full FDA approval, the US supports waiving IP protections for vaccines, and people in India struggle to get the aid they need. Here’s what you should know:
Want to receive this weekly roundup and other coronavirus news? Sign up here!
Pfizer and BioNTech ask the FDA for full approval of its shot for adults, and emergency use for teens
This morning, Pfizer and BioNTech asked the FDA for full approval of their Covid-19 vaccine for Americans 16 and up. The agency granted the shot emergency use authorization in December after it had two months of safety and efficacy data. Full
→ Continue reading at Wired - Science